Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
absent, Adstiladrin, adware, al, alive, Ann, authentication, Babjuk, beneficiary, BJU, Bristol, Bryan, caption, center, chilled, Coll, Connecticut, credential, cybersecurity, deceptive, deficient, degradation, deploying, destruction, diligence, downturn, email, encryption, Engl, ESG, fifteen, floating, FTC, fulguration, Grasso, guideline, hardware, harvesting, highlighted, honor, indemnification, IRA, landscape, lending, misrepresentative, mobility, monoclonal, necessitate, Nielsen, notified, notify, offline, outpace, penalize, phishing, prompted, proof, proportionately, reallocation, relocate, reluctant, remeasuring, rescind, resiquimod, resurgence, retaliatory, Rhijn, SEER, server, Simon, software, Squibb, strike, stuffing, summer, Surg, SURGE, SURGERx, tenor, theft, Tobert, transmit, unfair, unfairly, unreasonable, unstable, Utah, vast, venture, wiretapping, withdrew, worker, Yeung
Removed:
acid, Alzheimer, amine, apportioned, atezolizumab, avelumab, Bavenico, billion, biologic, Celgene, certified, checkpoint, clostridial, commitment, concurrently, conform, consecutive, cooled, deducting, Directive, dispensed, dose, dubbed, durvalumab, electrical, Encouragement, enhance, evolve, freedom, gap, Granot, IIA, Imfinzi, imidazoquinolin, impartial, Industrial, lactic, loaned, Namenda, nondeductible, nonstatutory, OAB, oral, Oraqix, pembrolizumab, periodontal, Poverty, preclinical, replacing, ruling, Scientist, simple, solid, spent, Tecentriq, terrorism, uncured, underserved, underwriting, underwritten, unwind, word, Xeloda
Filing tables
Filing exhibits
Related press release
Associated URGN transcripts
URGN similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-268398) and Form S-8 (Nos. 333-266761, 333-263729, 333-258496, 333-243750, 333-232034, 333-227812, 333-222955, 333-221212 and 333-218992) of UroGen Pharma Ltd. of our report dated March 24, 2023 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Florham Park, New Jersey
March 24, 2023